141 related articles for article (PubMed ID: 2507817)
1. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].
Tsukamura M
Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817
[TBL] [Abstract][Full Text] [Related]
2. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
Tsukamura M
Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of clinical efficacy of rifampicin in the treatment of nontuberculous mycobacteriosis from in vitro susceptibility testing].
Tsukamura M
Kekkaku; 1989 Jul; 64(7):453-8. PubMed ID: 2585946
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
Tsukamura M
Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y
Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
[TBL] [Abstract][Full Text] [Related]
6. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
Tsukamura M
Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
[TBL] [Abstract][Full Text] [Related]
7. [Bactericidal activity of ofloxacin against Mycobacterium kansasii].
Tsukamura M
Kekkaku; 1990 Nov; 65(11):719-21. PubMed ID: 2277465
[TBL] [Abstract][Full Text] [Related]
8. [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria].
Yamane N; Onaga S; Saitoh H; Toyoshima S; Shimojima M; Kawahara S; Takashima T; Yamashita T
Rinsho Byori; 2002 Apr; 50(4):381-91. PubMed ID: 12014018
[TBL] [Abstract][Full Text] [Related]
9. [Drug susceptibility test for Mycobacterium tuberculosis using non-radioactive substance, alpha-antigen].
Shigeto E; Taska H
Kekkaku; 1996 Mar; 71(3):245-52. PubMed ID: 8901226
[TBL] [Abstract][Full Text] [Related]
10. [Mycobacterial tests].
Takashima T; Higuchi T
Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
[TBL] [Abstract][Full Text] [Related]
11. [Bactericidal activity of antituberculosis drugs against Mycobacterium avium complex].
Tsukamura M
Kekkaku; 1990 Jan; 65(1):9-12. PubMed ID: 2313966
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of mycobacteria growth indicator tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis isolates].
Suzuki K; Tsuyuguchi K; Matsumoto H; Niimi A; Tanaka E; Murayama T; Amitani R; Kuze F
Kekkaku; 1997 Apr; 72(4):187-92. PubMed ID: 9145648
[TBL] [Abstract][Full Text] [Related]
13. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
Truffot-Pernot C; Giroir AM; Maury L; Grosset J
Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
[TBL] [Abstract][Full Text] [Related]
14. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
Tsukamura M
Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
[TBL] [Abstract][Full Text] [Related]
15. [Utility of the direct culture examination (Ziehl-Neelsen) using the Bactec system for the presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium xenopi, and Mycobacterium kansasii].
Moreno C; Garrigó M; Sánchez F; Coll P
Enferm Infecc Microbiol Clin; 1994 May; 12(5):241-5. PubMed ID: 7811323
[TBL] [Abstract][Full Text] [Related]
16. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
17. [In vitro antimycobacterial activity of a new quinolone, T-3761].
Tomioka H; Sato K; Saito H
Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
[TBL] [Abstract][Full Text] [Related]
18. [Cross-resistance relationships of antituberculosis drugs in Mycobacterium avium complex].
Tsukamura M
Kekkaku; 1989 Jan; 64(1):1-5. PubMed ID: 2709652
[TBL] [Abstract][Full Text] [Related]
19. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
Abe C
Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
[TBL] [Abstract][Full Text] [Related]
20. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
Young LS; Berlin OG; Inderlied CB
Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
